Trump Media stock slides again in premarket as DJT traders digest the fusion deal
30 December 2025
1 min read

Trump Media stock slides again in premarket as DJT traders digest the fusion deal

NEW YORK, December 30, 2025, 08:05 ET — Premarket

  • DJT was down about 0.8% in premarket trade after sliding 4.4% on Monday.
  • The stock has stayed volatile since Trump Media’s surprise fusion-merger plan with TAE Technologies.
  • Traders are watching for merger-related SEC filings and clarity on timing ahead of the regular session.

Trump Media & Technology Group Corp shares slipped in premarket trading on Tuesday, with DJT last down about 0.8% at $13.06 as of 7:57 a.m. ET. The stock closed Monday down 4.4% at $13.16. 1

The move keeps the spotlight on a retail-trader favorite that has swung sharply since the company unveiled a deal to combine with nuclear fusion developer TAE Technologies earlier this month. 2

Why it matters now: the transaction is expected to take months to clear regulators and shareholders, leaving the stock trading on headlines and thin year-end liquidity. Investors are also weighing Trump Media’s cash commitment to the deal against its core social-media business. 2

Monday’s session ranged from $13.13 to $13.65 and drew about 8.9 million shares of volume, StockAnalysis.com data showed. DJT’s premarket print sat below Monday’s low. 1

Trump Media and TAE said the transaction is an all-stock deal valued at more than $6 billion and is expected to close in mid-2026, subject to approvals. In an all-stock deal, the buyer pays with shares rather than cash; the companies also referenced VWAP, or volume-weighted average price, a common measure of the average trading price. 3

“Trump Media gets a dramatic new growth story tied to the AI power crunch,” Michael Ashley Schulman, partner and chief investment officer at Running Point Capital Advisors, said in a note on the announcement. 2

The pitch hinges on booming electricity demand from data centers, but fusion remains years from commercial use and has yet to produce a widely proven, profitable reactor. Reuters reported on the deal announcement that broader interest in nuclear power has revived as technology firms chase reliable power supply. 2

Trump Media’s financial profile has also kept skeptics active. The company reported a wider quarterly loss and a decline in revenue in its most recently reported quarter, Reuters reported in November. 4

The broader tape may not help. U.S. stock index futures steadied early Tuesday after a tech-led selloff in the prior session, with investors bracing for light trading volumes into the New Year’s holiday and watching for Federal Reserve meeting minutes for clues on rates. 5

For DJT, the next concrete milestone is paperwork. The companies have said Trump Media would provide up to $200 million in cash at signing and another $100 million upon the initial filing of a Form S-4 — the SEC registration statement used for stock-for-stock mergers — alongside the proxy materials needed for a shareholder vote. 2

Earnings are another near-term checkpoint. MarketChameleon estimates Trump Media’s next results could land between Feb. 13 and Feb. 17, 2026, though it said the company has not announced a date. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Palantir stock slips today as Fed minutes loom and AI-linked tech cools
Previous Story

Palantir stock slips today as Fed minutes loom and AI-linked tech cools

Amazon stock today: AMZN slips after appeals court rebuffs NLRB challenge as Fed minutes loom
Next Story

Amazon stock today: AMZN slips after appeals court rebuffs NLRB challenge as Fed minutes loom

Go toTop